Profile
| Metric | Value |
|---|---|
| Name | iShares Genomics Immunology and Healthcare ETF |
| Assets Under Management | $139M |
| Expense Ratio | 0.47% |
| Asset Class | Equity |
| Domicile | US |
| Inception Date | |
| Net Asset Value | 28K USD |
| Website | ishares.com |
| Last Ex-Dividend Date | |
| Next Ex-Dividend Date | N/A |
Top 30 Holdings
| Name | Ticker | Weight |
|---|---|---|
| RVMD | 5.15% | |
| MRNA | 4.67% | |
| BAYN.DE | 4.54% | |
| 4502.T | 4.36% | |
| REGN | 4.26% | |
| MRK | 4.25% | |
| ROG.SW | 4.20% | |
| GMAB.CO | 4.05% | |
| GSK.L | 4.03% | |
| IPN.PA | 3.98% | |
| INCY | 3.95% | |
| VRTX | 3.94% | |
| BNTX | 3.92% | |
| EXEL | 3.80% | |
| SAN.PA | 3.73% | |
| CAI | 3.65% | |
| IDYA | 3.42% | |
| ACLX | 3.12% | |
| TWST | 2.27% | |
| NUVB | 2.26% | |
| CRSP | 1.96% | |
| 4528.T | 1.93% | |
| RCUS | 1.79% | |
| NVAX | 1.22% | |
| ABCL | 1.06% | |
| IOVA | 0.97% | |
| KURA | 0.90% | |
| RIGL | 0.88% | |
| JANX | 0.84% | |
| IBRX | 0.83% |
Chart
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $29.00 | ||
| $23.66 | ||
| SMA 200 vs Price | -18.42% | |
| $27.52 | ||
| SMA 50 vs Price | -5.11% | |
| 0.81 | ||
| $0.61 | ||
| 55.78 | ||
| 25.44% | ||
| 26.71% |
Dividends
| Metric | Date | Value |
|---|---|---|
| $0.16 | ||
| N/A | N/A | |
| 1.06% | ||
| $0.31 |
Country Weights
| Country | Weight |
|---|---|
| United States | 57.87% |
| France | 8.52% |
| Germany | 8.37% |
| Japan | 6.26% |
| Switzerland | 6.04% |
| Denmark | 4.09% |
| United Kingdom | 4.05% |
| China | 2.31% |
| Canada | 1.12% |
| South Korea | 0.64% |
| Luxembourg | 0.55% |
Sector Weights
| Sector | Weight |
|---|---|
| Healthcare | 65.30% |
FAQ
Does IDNA pay dividends?
Yes, the iShares Genomics Immunology and Healthcare ETF does pays dividends, with the most recent payment being $0.16 per share. The last ex-dividend date was on December 16, 2025, and the next ex-dividend date has not been announced yet
What stocks are in IDNA?
As of today, iShares Genomics Immunology and Healthcare ETF includes 63 holdings, with 36 of them being companies from 11 different countries and 1 sectors. The most weighted holdings are Revolution Medicines, Inc. (5.15%), Moderna, Inc. (4.67%) and BAYER AG (4.54%)
What is the current assets under management for IDNA?
Assets under management of iShares Genomics Immunology and Healthcare ETF is $139M
What is IDNA average volume?
Average volume of iShares Genomics Immunology and Healthcare ETF is $34K
What is IDNA expense ratio?
Expense ratio of iShares Genomics Immunology and Healthcare ETF is 0.47%
What is IDNA inception date?
Inception date of iShares Genomics Immunology and Healthcare ETF is June 11, 2019
Data Sources & References
- IDNA Official Website www.ishares.com/us/products/308878/ishares-genomics-immunology-and-healthcare-etf
- IDNA Profile on Yahoo Finance finance.yahoo.com/quote/IDNA